Results 161 to 170 of about 52,753 (266)

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results [PDF]

, 2013
Princy Kumar, Edwin DeJesus, Gregory Huhn, Louis Sloan, Catherine B. Small, Howard Edelstein, Franco Felizarta, Ritche Hao, Lisa Ross, Britt Stancil, Keith A. Pappa, Belinda Ha, Belinda Ha   +12 more
openalex   +1 more source

48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial [PDF]

, 2014
Yazdan Yazdanpanah, M-A Khuong-Josses, Laurent Hocqueloux, Gilles Pialoux, J. Durant, Brian Wynne, Catherine Granier, Pablo Tebas, Keith A. Pappa, Sherene Min   +9 more
openalex   +1 more source

Dolutegravir in Real Life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho

, 2022
Jennifer Anne Brown, Bienvenu Lengo Nsakala, Kuena Mokhele, Itumeleng Rakuoane, Josephine Muhairwe, Tracy R. Glass, Alain Amstutz, Nadine Tschumi, Jennifer M. Belus, Thomas Klimkait, Niklaus Daniel Labhardt   +10 more
openalex   +1 more source

Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report. [PDF]

Cureus
Chowdhury AH, Chowdhury D, Jahan I, Woghiren A, Saleh M.   +4 more
europepmc   +1 more source

Correction: Electroencephalography as a diagnostic tool for late-onset efavirenz neurotoxicity syndrome. [PDF]

PLoS One
Nightingale S, Ssemmanda S, Tucker LM, Eastman RW, Lee Pan EB.   +4 more
europepmc   +1 more source

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana

, 2018
Thabo Diphoko, Simani Gaseitsiwe, Ishmael Kasvosve, Sikhulile Moyo, Harriet Okatch, Rosemary Musonda, Mark A. Wainberg, Joseph Makhema, Richard Marlink, Vladimir Novitsky, Max Essex   +10 more
openalex   +2 more sources

Efavirenz Treatment and False‐Positive Results in Benzodiazepine Screening Tests [PDF]

, 2009
Antje Blank, Victoria Hellstern, D. Schuster, Martin Hartmann, A. Matthee, Jürgen Burhenne, Walter E. Haefeli, Gerd Mikus   +7 more
openalex   +1 more source

Pharmacogenetics in Tuberculosis-HIV Coinfected Populations: A Systematic Review of Genetic Variants Influencing Antiretroviral and Anti-Tuberculosis Drug Response. [PDF]

J Multidiscip Healthc
Hardi H, Fitrianti Z, Mahata LE, Louisa M.   +3 more
europepmc   +1 more source

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

, 2014

openalex   +2 more sources

Transfer of TLC screening methods to quantitative HPTLC–densitometry methods for pharmaceutical products containing amlodipine besylate, cefpodoxime proxetil, cetirizine 2HCl, diclofenac sodium, efavirenz, mefenamic acid, and atovaquone + proguanil HCl [PDF]

, 2018
Bingsong Zeng, Yiru Gu, J. Sherma
openalex   +1 more source